Information on The List was supplied by individual companies through questionnaires and could not be independently verified by the Puget Sound Business Journal. Only those that responded to our ...
March 2026 healthcare stock update: see the top 10 $10B+ winners (IBRX, DVA, THC) plus ETFs, performance stats & Quant Ratings—read now.
India’s startup funding activity showed a mixed trend at the start of 2026. February recorded a sharp jump in total deal value despite limited big ticket funding. Monthly Funding Report ...
The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering rate, especially among the Mag Seven AI darlings, all while the question ...
Both of these players are leaders in their fields.
CRVS stock surged more than 200% in early 2026 as investors repriced its oral ITK inhibitor opportunity. Erasca Inc (ERAS) secured $258.8 million in fresh capital and holds patent protection on ...
Tanager Wealth Management exited its entire CNTA position, reducing holdings by 598,044 shares in the fourth quarter. As a result, the quarter-end position value decreased by $14.50 million, ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 9:50 AM ESTCompany ParticipantsJean-Paul Kress - Chairman ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, ...
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.